ConductScience.org, home

Gene · 2492

NIH grants1,110

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFSHR papersNewest fiscal year
R01HD082208Anti-Mullerian Hormone Actions to Control Primate Folliculogenesis22025
R01HL122010Decrypting Variants of Uncertain Significance in Long-QT Syndrome22025
R35GM127087The Evolution of Gene Regulation and Human Disease22025
ZIACP010201Laboratory of Translational Genomics22025
D43TW011302Capacity development for HIV and mental health research in Asia (CHIMERA)12025
D43TW011601Research Training: Chronic Non-Communicable CVDs and Comorbidities in Peru12025
F31CA284719Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas12025
K01AA030083Mass Multivariate Derivation and Validation of AUD Biotypes using Developmental Imaging and Genomic Approaches12025
K12GM106996IRACDA at UCLA12025
K12HD085809OHSU Women's Reproductive Health Research K12 Program12025
P01AG047200Comparative genomics of longevity and Alzheimer's disease12025
P01AI083214Harvard-wide Program on Antibiotic Resistance12025
P01CA163227Androgen Receptor Action in Castration Resistant Prostate Cancer12025
P20GM103427Nebraska Research Network in Functional Genomics12025
P20GM125503Center for Musculoskeletal Disease Research (CMDR)12025
P30AG024824Claude D. Pepper Older Americans Independence Center at the University of Michigan (UM Pepper Center)12025
P30CA006927Comprehensive Cancer Center Program at Fox Chase12025
P30CA012197Cancer Center Support Grant12025
P30CA013330Cancer Center Support Grant12025
P30CA014195Cancer Center Support Grant (CCSG)12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2492/grants?page=3